Cargando…

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence

Background: Currently, limited data on targeted therapy and immunotherapy sequencing in patients with BRAF-mutant melanoma is available. Targeted therapy and immunotherapy are expected to be comparable in terms of overall survival (OS) when used as second-line therapies; therefore, understanding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogala, Paweł, Czarnecka, Anna M., Cybulska-Stopa, Bożena, Ostaszewski, Krzysztof, Piejko, Karolina, Ziętek, Marcin, Dziura, Robert, Rutkowska, Ewa, Galus, Łukasz, Kempa-Kamińska, Natasza, Calik, Jacek, Sałek-Zań, Agata, Zemełka, Tomasz, Bal, Wiesław, Kamycka, Agnieszka, Świtaj, Tomasz, Kamińska-Winciorek, Grażyna, Suwiński, Rafał, Mackiewicz, Jacek, Rutkowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032972/ https://www.ncbi.nlm.nih.gov/pubmed/35456332 http://dx.doi.org/10.3390/jcm11082239

Ejemplares similares

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
por: Rogala, Paweł, et al.
Publicado: (2022)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
por: Placzke, Joanna, et al.
Publicado: (2023)

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies
por: Ziętek, Marcin, et al.
Publicado: (2022)

Real-world treatment practice in patients with advanced melanoma
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions
por: Czarnecka, Anna M, et al.
Publicado: (2023)

Neglected malignant neoplasms with cutaneous involvement
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2021)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
por: Ziętek, Marcin, et al.
Publicado: (2023)

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2022)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Dermoscopy of acute radiation-induced dermatitis in patients with head and neck cancers treated with radiotherapy
por: Pilśniak, Aleksandra, et al.
Publicado: (2023)

Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients
por: Kamińska, Paula, et al.
Publicado: (2023)

Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2016)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma
por: Czarnecka, Anna M., et al.
Publicado: (2021)

Systemic treatment in patients with malignant pleural mesothelioma – real life experience
por: Ziółkowska, Barbara, et al.
Publicado: (2022)

Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis
por: Spałek, Mateusz Jacek, et al.
Publicado: (2021)

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
por: Rutkowski, Piotr, et al.
Publicado: (2015)

Basal Cell Carcinoma Treated with High Dose Rate (HDR) Brachytherapy—Early Evaluation of Clinical and Dermoscopic Patterns during Irradiation
por: Krzysztofiak, Tomasz, et al.
Publicado: (2021)

Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer’s Response
por: Krzysztofiak, Tomasz, et al.
Publicado: (2023)

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Dermoscopy of halo nevus in own observation
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2014)

Dermoscopy on nevus comedonicus: a case report and review of the literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2013)

Tips and tricks in the dermoscopy of pigmented lesions
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2012)

The most common mistakes on dermatoscopy of melanocytic lesions
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2015)

What Do the Lips Say in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation? A Case Series
por: Szlauer-Stefańska, Anastazja, et al.
Publicado: (2021)

Advances in Molecular Characterization and Targeted Therapy in Dermatofibrosarcoma Protuberans
por: Rutkowski, Piotr, et al.
Publicado: (2011)

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
por: Sobczuk, Paweł, et al.
Publicado: (2022)

Urine Proteomic Study in OAB Patients—Preliminary Report
por: Futyma, Konrad, et al.
Publicado: (2020)

Dermoscopy of accessory nipples in authors’ own study
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2014)

“Mistletoe sign”: probably a new dermoscopic descriptor for melanoma in situ and melanocytic junctional nevus in the inflammatory stage
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
por: Tomela, Katarzyna, et al.
Publicado: (2023)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Multiple segmental piloleiomyoma: unrecognised entity
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2023)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qaia3j831t1s6voh8bmdbbhmjr